Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verrica Pharmaceuticals Inc.

0.4400
+0.02485.97%
Post-market: 0.44000.00000.00%16:02 EDT
Volume:213.01K
Turnover:94.43K
Market Cap:40.68M
PE:-0.30
High:0.4614
Open:0.4100
Low:0.4100
Close:0.4152
Loading ...

Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
·
12 Mar

Verrica Pharmaceuticals Inc expected to post a loss of 26 cents a share - Earnings Preview

Reuters
·
07 Mar

Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 11, 2025

GlobeNewswire
·
03 Mar

Verrica Pharmaceuticals Inc. (VRCA) Expected to Beat Earnings Estimates: Should You Buy?

Zacks
·
27 Feb

Verrica Pharmaceuticals Inc expected to post a loss of 26 cents a share - Earnings Preview

Reuters
·
24 Feb

Verrica Pharmaceuticals - Waiver Includes Requirements That There Be No 'Going Concern' Qualification for 2024 and Q1 2025

THOMSON REUTERS
·
22 Feb

Shareholders Can't Ignore US$1.1m Of Sales By Verrica Pharmaceuticals Insiders

Simply Wall St.
·
24 Jan

Verrica Pharmaceuticals Announces Presentation of Three Posters Featuring Positive Preliminary Topline Results of Vp-315 for the Treatment of Basal Cell Carcinoma at the 2025 Winter Clinical Dermatology Conference

THOMSON REUTERS
·
21 Jan

Verrica Pharmaceuticals Inc : Jefferies Cuts Target Price to $3 From $12

THOMSON REUTERS
·
07 Jan

Needham Sticks to Their Hold Rating for Verrica Pharmaceuticals (VRCA)

TIPRANKS
·
21 Dec 2024

Verrica Pharmaceuticals Inc: Seeing Favorable Changes in Demand Dynamics for Ycanth

THOMSON REUTERS
·
20 Dec 2024

Verrica Provides Business and Operational Update

THOMSON REUTERS
·
20 Dec 2024

Verrica Provides Business and Operational Update

GlobeNewswire
·
20 Dec 2024

BRIEF-Verrica Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
10 Dec 2024

Verrica Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
10 Dec 2024

Verrica Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
10 Dec 2024

Verrica Pharmaceuticals' Partner Torii Seeks Japan Approval for Skin Infection Treatment

MT Newswires Live
·
06 Dec 2024

Verrica announces development partner Torii files NDA for TO-208 in Japan

TIPRANKS
·
06 Dec 2024

BRIEF-Verrica Pharmaceuticals Announces that Development Partner Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in Japan

Reuters
·
06 Dec 2024

Verrica Pharmaceuticals Announces That Development Partner Torii Pharmaceutical Files New Drug Application of to-208 the Treatment of Molluscum Contagiosum in Japan

THOMSON REUTERS
·
06 Dec 2024